From: TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
TRMT6 High | TRMT6 Low | p-value | |
---|---|---|---|
Age (year) | 1 | ||
> = 50 | 18 | 18 | |
< 50 | 20 | 20 | |
Gender | 0.69161 | ||
Male | 34 | 35 | |
Female | 4 | 3 | |
BCLC stage | 0.26674 | ||
A | 13 | 20 | |
B | 8 | 4 | |
C | 16 | 14 | |
D | 1 | 0 | |
Tumour-Node-Metastasis (TNM) stage | 0.00006 | ||
I | 5 | 17 | |
II | 15 | 3 | |
III | 7 | 12 | |
IV | 11 | 6 | |
Primary tumor (T) classification | 0.00191 | ||
T1 | 5 | 17 | |
T2 | 20 | 7 | |
T3 | 8 | 12 | |
T4 | 5 | 2 | |
Regional lymph node (N) classification | 0.010701 | ||
N0 | 32 | 38 | |
N1 | 6 | 0 | |
Distant metastasis (M) classification | 0.168716 | ||
M0 | 27 | 32 | |
M1 | 11 | 6 | |
Recurrence | 0.22186 | ||
No | 10 | 15 | |
Yes | 28 | 23 | |
Portal vein tumor thrombus | 0.236593 | ||
No | 33 | 31 | |
Yes | 5 | 7 | |
Microscopic tumor thrombus | 0.118061 | ||
No | 25 | 31 | |
Yes | 13 | 7 |